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Impaired Precursor B Cell Differentiation in Bruton’s Tyrosine
Kinase-Deficient Mice1
Sabine Middendorp, Gemma M. Dingjan, and Rudolf W. Hendriks2
Bruton’s tyrosine kinase (Btk) is a cytoplasmic signaling molecule that is crucial for precursor (pre-B) cell differentiation in
humans. In this study, we show that during the transition of large cycling to small resting pre-B cells in the mouse, Btk-deficient
cells failed to efficiently modulate the expression of CD43, surrogate L chain, CD2, and CD25. In an analysis of the kinetics of pre-B
cell differentiation in vivo, Btk-deficient cells manifested a specific developmental delay within the small pre-B cell compartment
of 3 h, when compared with wild-type cells. Likewise, in in vitro bone marrow cultures, Btk-deficient large cycling pre-B cells
showed increased IL-7 mediated expansion and reduced developmental progression into noncycling CD2CD25 surrogate L
chain-negative small pre-B cells and subsequently into Ig-positive B cells. Furthermore, the absence of Btk resulted in increased
proliferative responses to IL-7 in recombination-activating gene-1-deficient pro-B cells. These findings identify a novel role for Btk
in the regulation of the differentiation stage-specific modulation of IL-7 responsiveness in pro-B and pre-B cells. Moreover, our
results show that Btk is critical for an efficient transit through the small pre-B cell compartment, thereby regulating cell surface
phenotype changes during the developmental progression of cytoplasmic  H chain expressing pre-B cells into immature IgM
B cells. The Journal of Immunology, 2002, 168: 2695–2703.
B ruton’s tyrosine kinase (Btk)3 belongs to the Tec familyof cytoplasmic protein tyrosine kinases and plays an es-sential role in B lymphocyte development and function
(1, 2). In mature B cells, Btk is tyrosine phosphorylated and its
kinase activity is increased upon B cell receptor (BCR) stimulation
(3–5).
Mutations in the Btk gene lead to X-linked agammaglobulinae-
mia (XLA) in humans and X-linked immunodeficiency (xid) in the
mouse (6–9). XLA is characterized by recurrent bacterial infec-
tions, and very low serum Ig levels of all classes due to the lack of
plasma cells in the secondary lymphoid organs. There is a severe
deficiency of peripheral B cells, and those B cells that are present
have an aberrant IgMhigh phenotype (10). In the bone marrow
(BM) of XLA patients, the numbers of cytoplasmic  H chain
(c)-expressing pre-B cells are variable, but in most cases re-
duced; those pre-B cells present are mainly nonproliferating small
cells (11–13). The absence of Btk apparently results in deficient
expansion of the earliest c-expressing pre-B cells. Therefore, the
XLA disease phenotype most likely reflects defective signaling
through the pre-BCR, by which the expression of a functional  H
chain normally is monitored, together with surrogate L chain
(SLC; Ref. 14). As most patients have substantial numbers of
pro-B cells in their BM, XLA generally results in an increased
ratio of pro-B to pre-B cells (11–13).
In contrast, Btk deficiency in the mouse is associated with an
impairment of peripheral B cell maturation, without a major early
B cell developmental block (15–17). In xid mice the mature
IgMlowIgDhigh B cell populations in spleen and lymph nodes are
severely reduced, B-1 B cells are absent, and serum IgM and IgG3
levels are low. Xid B cells do not proliferate upon surface IgM
(sIgM) stimulation. The most obvious difference between the BM
B cell compartment of wild-type (WT) mice and Btk-deficient
mice is the reduction in mature recirculating cells (15–17). The
absolute numbers of pre-B cells that are generated in the BM of
Btk-deficient mice are normal, and Btk-deficient B cell precursors
in the BM have the same kinetics of turnover (18, 19). Neverthe-
less, several lines of evidence point at a role for Btk at the tran-
sition of pre-B cells into immature surface Ig B cells, thereby
indicating the involvement of Btk in pre-BCR signaling in the
mouse. Using an in vivo competition assay in heterozygous
Btk/ female mice, we identified a small but significant selective
disadvantage of Btk-deficient cells to contribute to the IgMIgD
immature B cells stage in the BM (17). Our recent finding of an
intrinsic reduction of Ig  L chain usage in Btk-deficient B cells in
the mouse implicated Btk in the activation of gene rearrangements
at the  L chain locus (20). Furthermore, while mice deficient for
another Tec kinase family member, Tec, showed normal B cell
development, an almost complete block at the CD43B220 stage
of B cell development was observed in Btk/Tec double-deficient
mice (21). These results indicated that Btk is critically involved in
pre-BCR-mediated signaling in the mouse and that Tec is able to
compensate for the loss of Btk during early B cell development. A
role for Btk in pre-BCR signaling would be consistent with the
recent finding that Btk is able to function in CD79b (Ig)-mediated
signaling in recombination-activating gene (RAG)-2-deficient
pro-B cells (22).
To examine the role of Btk at the pre-BCR checkpoint in vivo,
we compared the expression of early B cell surface markers in the
BM from Btk-deficient and WT control mice. In this report, we
show that Btk is involved in the pre-BCR-dependent induction of
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cell surface phenotype changes during the progression of large
cycling c pre-B cells into surface Ig immature B cells, thereby
affecting the transit time through the small pre-B cell compart-
ment. In addition, we performed IL-7-driven BM cultures, which
point at a role for Btk in the differentiation stage-specific modu-
lation of IL-7 responsiveness in early murine B cell development,
even in stages preceding c expression.
Materials and Methods
Mice and genotyping
Btk/lacZ mice (17) were crossed onto a C57BL/6 background for 6
generations. Specific experiments were additionally performed with Btk
mice on a mixed C57BL/6  129 or C57BL/6  FVB background, but no
significant influence of the genetic background was observed. RAG-1/
mice (23) were on a 129/Sv background. All mice were bred and main-
tained in the animal care facility at the Erasmus Medical Center, Rotterdam
(Rotterdam, The Netherlands). To determine the Btk genotype, tail DNA
was analyzed by Southern blotting of BamHI digests, as described (17).
The RAG-1 genotype was determined using a 1.9-kb partial RAG-1 probe
(encoding amino acid positions 387-1008, kindly provided by D. van Gent,
Erasmus Medical Center) to hybridize to BamHI-NcoI genomic digests (23).
Flow cytometric analysis
Preparations of single-cell suspensions, flow cytometry, and determination
of -galactosidase activity by loading cells with fluorescein-di--D-galac-
topyranoside substrate (Molecular Probes Europe, Leiden, The Nether-
lands), have previously been described (17, 24). Events (13  105) were
scored using a FACSCalibur flow cytometer and analyzed by CellQuest
software (BD Biosciences, Mountain View, CA). The following mAbs
were obtained from BD PharMingen (San Diego, CA): FITC-conjugated
anti-BP-1/6C3, anti-B220/RA3-6B2, anti-(R5-240), and anti-IgM (II/41);
PE-conjugated anti-CD2, anti-(187.1), anti-CD25, and anti-CD43; Cy-
Chrome-conjugated anti-B220/RA3-6B2 and biotinylated anti-IL7R, anti-
(187.1), anti-1/2(R26-46), and anti-IgM (II/41). PE-conjugated IgD was
obtained from Southern Biotechnology Associates (Birmingham, AL). Bi-
otinylated anti-SLC Ab LM34 (25) was kindly provided by A. Rolink
(Basel Institute for Immunology, Basel, Switzerland). Secondary Abs were
PE-, tricolor-, or APC-conjugated streptavidin, purchased from Caltag Lab-
oratories (Burlingame, CA).
For intracellular flow cytometric detection of cytoplasmic Ig H or L
chain or SLC, the following Abs were applied: FITC-conjugated anti-Ig
(R5-240, BD PharMingen) or polyclonal anti-Ig  H chain (Jackson Im-
munoresearch Laboratories, West Grove, PA) and biotinylated anti-1/2
(BD PharMingen), or anti-SLC (LM34). Cells were first stained for cell
surface markers and subsequently fixed in 2% paraformaldehyde and per-
meabilized using 0.5% saponin.
Cell cycle analysis
To analyze cell cycle status of cultured cell suspensions, cells were incu-
bated in ice-cold ethanol for 2 h. Subsequently, cells were incubated at
room temperature for 30 min in PBS containing 0.02 mg/ml propidium
iodide, 0.1% v/v Triton X-100, and 0.2 mg/ml RNase, left overnight at 4°C,
and analyzed with a FACSCalibur flow cytometer. Doublet cells were ex-
cluded from the analysis by measuring peak area and width. For simulta-
neous analysis of cell surface markers, c expression, and DNA content,
we used a method described by Constantinescu and Schlissel (26). Cells
were sequentially stained for surface CD2 expression using PE-labeled
anti-CD2, for c using polyclonal anti- H chain, and 7-aminoactinomy-
cin-D (7-AAD, Molecular Probes Europe).
IL-7-driven BM cultures
Primary pre-B cell cultures were essentially performed as described pre-
viously (20), using erythrocyte-depleted total BM cell suspensions. For
specific experiments, BM cell suspensions were depleted of sIgM cells,
using biotinylated anti-IgM and streptavidin-coated microbeads, as de-
scribed (20). Recombinant murine IL-7 was from R&D Systems (Minne-
apolis, MN). To measure IL-7-dependent proliferative responses, cells
were cultured in flat-bottom 96-well plates for 5 days with various amounts
of IL-7 at different cell concentrations (0.25–1  105 cells/well). Cultures
were pulsed for 24 h with 0.5 Ci/well of [3H]thymidine, harvested on
glass-fiber filters, and the incorporated radioactivity was determined using
a beta counter, according to standard procedures.
In vivo 5-bromo-2-deoxyuridine (BrdU) labeling
BrdU (Sigma Aldrich, St. Louis, MO) was dissolved in PBS at 2 mg/ml.
Mice were injected i.p. with 200 l, and sacrificed at various time points.
Total BM cell suspensions were analyzed by flow cytometry for BrdU
incorporation, using the BrdU flow kit (BD PharMingen) in conjunction
with cell surface marker expression.
Results
Btk-c pre-B cells show a defective surface marker expression
profile
To investigate the involvement of Btk in pre-BCR signaling, we
compared the pre-B cell compartment in the BM of Btk and Btk
mice. Consistent with published findings (16, 17, 21), we did not
observe a major early B cell developmental block in Btk mice,
but only a small increase in the fraction of CD43 cells within the
population of sIgMB220 pro-/pre-B cells: 20–25% in Btk
and 50–55% in Btk mice (Fig. 1A).
About one-fifth of all pre-B cells have been reported to express
 H chain and L chains in their cytoplasm, without depositing IgM
on the cell surface (27). These cells may have down-regulated
sIgM expression due to autoantigen binding, or they may produce
Ig H and L chains that do not pair (14, 27). As previously de-
scribed (20), surface Ig B cell precursors of Btk mice showed
reduced expression of cytoplasmic L chain. Surface Ig B cells
(16  3%) expressed  L chain in the cytoplasm, compared with
23  2% in Btk mice, while the frequency of cytoplasmic 
expression pre-B cells was reduced by a factor3 (Fig. 1B). These
findings suggest reduced or delayed Ig L chain rearrangement.
Signaling through the pre-BCR initiates proliferative expansion
of those cells with a productively rearranged Ig H chain. Subse-
quently, these cells progress into small resting pre-B cells that have
changed their cell surface phenotype and initiate  and  L chain
rearrangement (14). Therefore, we analyzed IgMB220 B cell
precursors for the expression of several cell surface markers in
four-color flow cytometric experiments (Fig. 1C). In Btk mice,
the IgMB220 compartment contained a unique subpopulation
of CD43low cells which manifested increased expression of the
BP-1 molecule, a metallopeptidase that is selectively induced co-
incident with IL-7-driven pre-B cell proliferation (28). As soon as
a pre-BCR is expressed, the synthesis of SLC is turned off (29).
However, Btk cells had an increase in the fraction of
IgMB220 cells that expressed SLC in their cytoplasm, as com-
pared with Btk cells (Fig. 1C). In a specific analysis of c pre-B
cells, Btk mice showed significantly reduced expression of the
IL-2R CD25 (30  6%), and the CD2 adhesion molecule (32 
4%), as compared with Btk mice (66  7% and 70  6%, re-
spectively). These molecules were previously reported to be up-
regulated upon pre-BCR signaling (30, 31).
Collectively, these findings indicated that the absence of Btk
resulted in a defective progression of SLCCD43CD2CD25
into SLCCD43CD2CD25c pre-B cells. Analysis of the
absolute numbers of the various B-lineage subpopulations in the
BM (Table I) revealed that in Btk mice the size of the total
population of CD2 c early pre-B cells was increased with a
factor of 2.4, whereas the total population of CD2 c late
pre-B cells was decreased with a similar factor.
The developmental progression to CD2 late pre-B cells nor-
mally correlates with a change in cell cycle status, from large
cycling into small resting pre-B cells (26). This was confirmed by
the finding in Btk mice of 45% of CD2 and 10% of
CD2c pre-B cells in S, M, or G2 phase, using 7-AAD staining
for DNA content (Fig. 1C). In contrast, the CD2c pre-B cell
population in Btk mice contained only 23% of cycling cells,
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i.e., about half the number found in Btk mice. However, as the
size of the total population of CD2c pre-B cells was increased
with a factor 2.4 in Btk mice, we conclude that Btk and Btk
mice contain comparable numbers of large cycling c cells
(0.8  106 cells per hind leg).
In summary, the absence of Btk in pre-BCR signaling resulted
in defective down-regulation of CD43 and SLC, defective up-reg-
ulation of CD2 and CD25, augmented expression of BP-1, whereas
in vivo proliferative expansion of pre-B cells appeared to be
unaffected.
Table I. B-lineage subpopulations in Btk and Btk mice
Cell Population Btk (n  7) Btk (n  7) p Values
Total B220 cells 13.8  2.19a 11.1  2.78 NS
Total sIgMB220 cells 8.70  1.58 7.63  2.35 NS
Pro-B (c) 1.16  0.36 1.24  0.50 NS
Early pre-B (cCD2) 1.56  0.75 3.82  1.41 0.0028
Late pre-B (cCD2) 5.63  1.29 2.32  0.72 	0.0001
Immature B cells (sIgMsIgD) 2.22  0.51 2.01  0.57 NS
Mature B cells (sIgMsIgD) 1.83  0.54 0.86  0.37 0.0022
a Absolute number of cells (mean  SD  106) per hind leg.
FIGURE 1. Characterization of the pre-B cell compartment in Btk and Btk mice. A, BM cell suspensions were stained with mAbs to B220, CD43,
and IgM. The expression profiles of B220 and sIgM are shown (top). sIgM cells were analyzed for B220 and CD43 (bottom). Percentages of CD43 cells
within the indicated B220 gate are given. B, BM cell suspensions were stained with mAbs to detect surface expression of IgM, IgD, B220, and cytoplasmic
(c) expression of  or  L chain. The percentages of c and c cells within the IgMIgD B220 subpopulation are given. C, Four-color flow cytometric
analyses of BM cell suspensions, using mAbs to B220 and IgM, together with various additional mAbs. B220IgM pro-B/pre-B cells were electronically
gated and analyzed for the indicated markers. Cell cycle status was determined in cCD2 and cCD2 cells, using 7-AAD. The percentages of cycling
cells (S, M, or G2 phase) are indicated. Data shown are representative of three to eight mice examined.
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Btk cells show a developmental delay within the small pre-B
cell compartment in vivo
The inefficient induction of cell surface phenotype changes in
Btk mice at the pre-B cell stage was still noticeable at the next
developmental stage of IgM immature B cells. As shown by flow
cytometric analysis (Fig. 2A), IgMB220low immature B cells in
Btk mice manifested lower expression of CD2 (66  5%, n  9)
and CD25 (19  1%, n  12), compared with immature B cells in
Btk animals (CD2: 90 3%, n 8, and CD25: 36 1%, n
12). In addition, considerable fractions of Btk immature B cells
expressed surface BP-1 (45  3%, n  6) or cytoplasmic SLC
(13  3%, n  8), which were not detected in Btk immature B
cells (	3%; Fig. 2A).
To investigate whether the inefficient induction of cell surface
phenotype changes in Btk pre-B and immature B cells would be
associated with a delayed developmental progression into IgM
immature B cells, we estimated the transit time through the small
pre-B cell compartment. Btk and Btk mice were injected with
a single dose of the BrdU thymidine analog, which is specifically
incorporated into the DNA of large cycling pre-B cells (32–34).
BM cells were stained with an anti-BrdU Ab, in conjunction with
cell surface analysis for B220, IgD, and  or  L chain, and ana-
lyzed by flow cytometry. Twelve hours after injection, 30–35%
of Ig B cell precursors incorporated BrdU, both in Btk and
Btk mice. At various time points after BrdU injection, we ana-
lyzed BrdU incorporation within  and  IgD immature B
cells. As shown for the 48-h time point in Fig. 2B, the fractions of
BrdU cells within the surface  or  immature B cells were
decreased in Btk mice when compared with Btk mice. As small
pre-B cells are noncycling cells, the first appearance of BrdU
cells within the surface Ig immature B cells reflects the minimum
transit time through the small pre-B compartment. When for 
immature B cells, the data from six time points were subjected to
linear regression analysis (33), it was found that BrdU imma-
ture B cells emerged 8 h after BrdU injection in Btk mice and
only after 11 h in Btk mice (Fig. 2C). In agreement with re-
ported experiments (33, 34), BrdU immature B cells only
emerged 30 h after BrdU injection. Likewise, linear regression
analysis revealed a delay of 3.5 h for Btk-deficient  immature
B cells (32.5 h), as compared with Btk cells (29 h).
In summary, we conclude that in Btk mice the inefficient in-
duction of cell surface phenotype changes in  pre-B cells was
accompanied by a specific developmental delay within the small
pre-B cell compartment of 3 h. In addition, the immature B cells
generated manifest an aberrant surface phenotype.
Btk pre-B cells show deficient developmental progression in vitro
To further investigate the role of Btk in the developmental pro-
gression of c pre-B cells and the initiation of Ig L chain ex-
pression, IL-7-driven BM culture experiments were performed, as
described (35, 36). Pre-B cells that have a productive Ig H chain
rearrangement undergo rapid cell division in response to IL-7.
When IgM BM cell suspensions from Btk mice were cultured
in the presence of 100 U/ml IL-7 for 5 days, the majority of cells
consisted of B220IgM cells, while a significant fraction ma-
tured to sIgMIgD (10%) or IgMIgD B cell stages (5%)
(Fig. 3). This differentiation into IgM cells did not result from an
IL-7 insufficiency in culture, as it was also present when higher
IL-7 concentrations were used. In contrast, only 	5% and 	0.5%
of the Btk cells exhibited an IgMIgD or IgMIgD profile in
culture, respectively. Therefore, these findings indicated that Btk
signaling supported the progression from pre-B cell to surface Ig
B cell in vitro in the presence of IL-7. Similar differences were
observed, when cells were subsequently cultured for 48 h on S17
stroma cells in the presence of IL-7: 30% of BtkB220 cells
were surface Ig, but only 5% of BtkB220 cells (Fig. 3).
After removal of IL-7, which strongly induces the cells to exit
from cell cycle and to further differentiate (36), significant num-
bers of sIgM B cells were generated in the Btk BM cultures.
Nevertheless, when compared with Btk B cells, the maturation of
Btk B cells to the IgMIgD stage was reduced (Fig. 3). There-
fore, the analyses of IL-7-driven BM cultures showed that Btk
signaling promotes the maturation of pre-B cells into surface Ig
B cells in the presence of IL-7 in vitro.
FIGURE 2. Absence of Btk results in delayed developmental progres-
sion into immature B cells. A, Expression of CD2, CD25, cytoplasmic SLC
(cSLC), and BP-1 on B220lowIgM cells in BM of Btk (thin lines) and
Btk mice (bold lines). For cSLC analysis, histogram overlays of gated
B220 cells are shown as negative control stainings (dotted lines). The
percentages of positive cells are indicated above the marker line (Btk) and
below the marker line in bold (Btk). B, BrdU incorporation 48 h after
BrdU injection in Btk and Btk mice. BM cells were stained for surface
expression of B220, IgD, and  or , in conjunction with BrdU. Histograms
show BrdU staining in B220IgD immature B cells, with the percentages
of BrdU cells. C, Linear regression analysis of the appearance of BrdU
 and  immature B cells over time in Btk (open symbols) and Btk mice
(filled symbols). Each point represents BrdU staining of B220IgD/
BM cells from three to six mice per group (except for Btk mice, 30 h: n 
2). Entry points and slope values were 8 h and 1.3 (, Btk), 11 h and 1.2 (,
Btk), 29 h and 1.7 (, Btk), and 32.5 h and 1.3 (, Btk), respectively. As
evaluated by Student’s t test, the fractions of BrdU cells were significantly
lower in  Btk cells as compared with Btk cells, with p values of 	0.01
(12, 16, and 40 h),	0.02 (48 h), and 0.05 (21 h). For the 30-h time point, the
number of measurements was insufficient for a statistical evaluation. For  B
cells, the p values ranged from 	0.0001 to 	0.01 for the four time points
shown.
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Btk pre-B cells show enhanced IL-7-driven expansion in vitro
Next, we analyzed the kinetics of in vitro B cell development in
IL-7-driven BM cultures, using total BM cells from Btk, Btk,
and Btk/ mice, without S17 stroma. Similar results were ob-
tained in IL-7-driven BM cultures in the presence of S17 stromal
cells, either throughout the 7-day culture period or from day 5
onwards (data not shown).
In these experiments, we used biotinylated Abs to detect sIgM
expression, which resulted in higher fluorescence intensity values
(up to 2  103), as compared with the experiments described in
Fig. 3 (up to 5  102). We observed that most BtkB220 cells
stained with the anti- H chain Ab after culture with IL-7 (fluo-
rescence intensities ranging from 20 to 100; Fig. 4A). These cells
were c positive, surface, or cytoplasmic  or  negative, and
expressed SLC both in their cytoplasma and on the cell surface
(see Results; Fig. 5). Therefore, we concluded that these cells were
pre-B cells, and that the anti- H chain Ab staining in Btk cells
reflected high surface pre-BCR expression. In contrast, the Btk cells
with anti-IgM fluorescence intensities ranging from 20 to 100 were
surface  cytoplasmic SLC immature B cells (see Results; Fig. 5).
When compared with Btk cultures, Btk and Btk/ cultures
were characterized by a more rapid loss of mature surface Ig cells
(Fig. 4A, day 3), and a reduced appearance of newly formed Ig B
cells (Fig. 4A, days 5 and 7). From the total cell counts and the
flow cytometric analyses of the cells, the expansion rates of sIgM
and sIgMB220 cells during culture were calculated. As shown
in Fig. 4B, pre-B cell expansion was significantly higher in the
cultures from Btk mice (30) when compared with Btk mice
(	10). Only for Btk BM cells, the further differentiation of
pre-B cells generated in the cultures in the presence of IL-7 re-
sulted in an expansion of mature sIgM B cells (4).
Increased proliferation of Btk cells was confirmed by analysis
of cell cycle and cell size (Fig. 4C). After 5 days of culture, 53 
3% of the Btk cells (n  6) and only 25  3% of the Btk (n 
6) were in the S, M, or G2 phase of the cell cycle. In these exper-
iments, the Btk BM cultures contained higher proportions (77 
6%) of large cells with high forward scatter (FSC) values than the
Btk BM cultures (42 7%). To further quantify cell proliferation in
the presence of various concentrations of IL-7, we performed [3H]thy-
midine incorporation experiments. After 5 days of culture, Btk cells
showed significantly higher proliferative responses to IL-7 when com-
pared with Btk cells (Fig. 4D). These findings in Btk and Btk
BM cultures demonstrated that in the absence of Btk, IL-7-driven
pre-B cell proliferation in vitro is increased.
Enhanced IL-7-driven expansion and decreased developmental
progression is intrinsic to Btk pre-B cells
The observed differences in IL-7-driven proliferation between
Btk and Btk pre-B cells cannot easily be explained by increased
surface expression of IL-7R on these cells in Btk mice. In flow
cytometric experiments, the proportions of IL-7R chain positive
cells within the large pre-B cell population in Btk and Btk mice
were 77  4% and 87  2%, respectively, while the mean fluo-
rescence intensities of IL-7R cells were comparable.
To answer the question of whether the phenotype of Btk cells
in IL-7-driven BM cultures is an intrinsic feature of Btk pre-B
cells, or alternatively, originates from a defective BM microenvi-
ronment in Btk mice, we also investigated BM cultures from
Btk/ mice. Due to random X chromosome inactivation, the
pre-B cell compartment in these mice consists of two functionally
different populations, i.e., Btk and Btk (17, 37, 38). In Btk/
heterozygous mice, IL-7-driven pre-B cell proliferation was inter-
mediate between Btk and Btk mice, as measured by pre-B cell
expansion, cell cycle status, and [3H]thymidine incorporation (Fig.
4, B–D). At days 5 and 7, the surface Ig expression profiles and the
FSC values in Btk/ cultures were similar to those of Btk cells
(Fig. 4, A and C), indicating a proliferative advantage of Btk over
Btk cells. The presence of a lacZ reporter in the Btk allele
enabled a separate evaluation of the expansion of Btk/lacZ and
Btk/lacZ cells in Btk/ cultures. At days 5 and 7, the propor-
tions of lacZ cells in Btk/ and Btk cultures were comparable,
indicating an intrinsic selective advantage of Btk-deficient cells in
culture. In these cultures, the majority of IgM cells were Btk/
lacZ. Thus, the increased expansion and reduced differentiation
in IL-7-driven pre-B cell cultures is an intrinsic feature of Btk
cells, which is independent of the xid BM microenvironment in
vivo, or coculture of Btk-deficient stromal cells in the BM cultures.
Aberrant phenotype of Btk cells in IL-7-driven BM cultures
Next, we investigated whether the inefficient pre-BCR-mediated
induction of cell phenotype changes in Btk pre-B and immature
B cells in vivo were paralleled in the BM cultures in vitro. Large
and small IgM cells were obtained from total BM cultures in the
presence of IL-7 for 7 days. Small IgM cells were obtained from
total BM cell suspensions that were cultured in the presence of
IL-7 for 5 days and subsequently in the absence of IL-7 on S17
stromal cells for 2 days. In agreement with our findings in vivo
(Fig. 1), we found by flow cytometric analysis that in Btk cul-
tures down-regulation of CD43 and up-regulation of CD2 and
CD25 at the large to small pre-B cell transition was impaired (Fig.
5). The expression of BP-1 was elevated in all three stages ana-
lyzed. Most importantly, we noticed that in the absence of Btk,
SLC synthesis is not efficiently turned off, resulting in significantly
enhanced cytoplasmic and surface SLC expression in Btk large
pre-B cells (96  1% and 29  2%, n  3, respectively), com-
pared with 67  5% and 2.9  0.9% (n  3) in Btk cells. Also
in small pre-B cells, cytoplasmic SLC expression was enhanced in
Btk cultures (62 5%), compared with Btk cultures (17 3%;
FIGURE 3. Developmental progression of Btk and Btk cells in IL-
7-driven BM cultures. BM cells were cultured in the presence of IL-7 for
5 days and subsequently analyzed (“0 h”) or recultured on S17 stroma cells
in the presence or absence of IL-7 for 48 h. Cultured cells were stained for
B220, IgM, and IgD. B220 cells were gated and analyzed for the expres-
sion of IgM and IgD. Data shown are representative of 10 mice examined
in each group.
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Fig. 5). A small but reproducible increase in the expression level
of c was present in Btk-deficient large and small pre-B cells. In
addition, significant fractions of cytoplasmic  L chain-positive
pre-B cells were only present in Btk cultures (20% of small
sIgM pre-B cells, compared with 	2% in Btk-deficient pre-B
cells).
Taken together, these findings in IL-7-driven BM cultures con-
firm the involvement of Btk signaling in the pre-BCR-mediated
down-regulation of CD43 and SLC and the induction of CD2 and
CD25 expression, and the initiation of Ig L chain rearrangements.
Btk pro-B cells show significantly increased IL-7-driven
proliferation in vitro
To investigate whether Btk-dependent modulation of IL-7 respon-
siveness in the mouse is specific for the pre-B cell stage, or alter-
natively, also occurs in earlier stages of B cell development, we
crossed the Btk-deficient mice onto a RAG-1/ background. In
these mice, B cell development is arrested at the CD43 pro-B cell
stage, in which the BCR-linked CD79/CD79 heterodimers are
expressed on the cell surface without associated  H chains (39).
Btk and BtkRAG-1/ mice contained similar numbers of
CD43B220 pro-B cells in vivo (data not shown), but the ex-
pression of IL-7R was slightly different (62% in Btk and
79% in BtkRAG-1/ mice). In [3H]thymidine incorporation
experiments, IL-7-induced proliferation was significantly en-
hanced in BtkRAG-1/ pro-B cells, when compared with con-
trol BtkRAG-1/ pro-B cells (Fig. 6A). Whereas we did not
detect significant differences between the two groups of mice in the
in vivo expression of the BP-1, the expression was elevated in the
BtkRAG-1/BM cultures (Fig. 6B). Collectively, these results
indicate that Btk-signaling can modulate the responsiveness to
IL-7 of early B cell precursors, even before pre-BCR expression.
Discussion
Btk and pre-BCR signaling
Signaling through the pre-BCR complex mediates the checkpoint
function of  H chain by inducing cell cycle entry and rapid down-
regulation of the rearrangement machinery, thereby ensuring al-
lelic exclusion (14, 29). Subsequently, the proliferating pre-B cells
exit the cell cycle, change the expression profile of various cell
surface markers, and perform Ig L chain rearrangements with
sequential activation of the  and the  loci (14). In humans,
mutations in the Btk gene result in XLA, which reflects an al-
most complete block in B cell development at the pre-B cell
stage (12, 13, 40). Similar to findings in mice deficient for the
FIGURE 4. Analysis of IL-7-driven BM cultures from Btk, Btk, and Btk/ heterozygous female mice. A, IgM/IgD expression profile of B220 cells
in uncultured BM samples, as well as after the indicated days of culture in the presence of IL-7. The gates for the pre-B cells (sIgM-/low), immature B cells
(IgMIgD), and mature B cells (IgD) are indicated, as well as the percentages of cells within the B cell gates. Note that the pre-B vs immature B gate
settings for Btk and Btk mice at days 3, 5, and 7 are almost one log different, as they are based on differential expression of , , and SLC in parallel
stainings (see Results). Dot plots are representative of 8–11 mice per group. B, Expansion of IgM pre-B cells and IgM B cells during culture with IL-7.
The four bars per group indicate the expansion at days 3, 5, and 7, as compared with the IgM and IgM (pre-)B cell numbers at the start of the culture,
which were set to one. The plot is representative of six experiments using 2–4 mice per group. Error bars are the SD from three mice within every group.
C, Cell cycle status and cell size after 5 days of culture with IL-7 from Btk, Btk, and Btk/ mice. DNA content of total cultured cells was examined
by propidium iodide staining. The percentages of cycling cells (S, M, or G2 phase) are indicated. Cell size was examined in B220IgMIgD pre-B cells.
Numbers indicate the percentage of cells with a FSC value 600. Histograms are representative of five to six mice per group. D, Proliferative responses
to the indicated concentrations of IL-7, as determined by [3H]thymidine incorporation after 5 days of culture. Error bars are the SD from three mice within
every group. The plot is representative of three experiments.
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SLC component 5 or the membrane form of the Ig  H chain
(41, 42), most XLA patients lack the compartment of large cy-
cling pre-B cells (13). Therefore, the XLA disease phenotype
implicates Btk in the pre-BCR signaling-mediated expansion of
those pre-B cells with a productive  H chain rearrangement in
humans.
In contrast, Btk is not essential for the selective expansion of
c pre-B cells in the mouse, as in Btk-deficient mice the pre-B
cell population is normal in size and contains normal proportions
of cycling cells (16–19). In this report, we demonstrate that the
mouse Btk is involved in later phases of pre-B cell differentiation.
We compared the pre-B cell compartment in Btk mice and Btk
mice both in vivo and in vitro in IL-7-driven BM cultures. The
absence of Btk resulted in 1) defective down-regulation of CD43
and SLC expression, 2) impaired up-regulation of CD2 and CD25,
3) aberrant expression of BP-1, 4) a 3-h delay in B cell develop-
ment in vivo at the small pre-B cell stage and reduced progression
to surface Ig B cells in vitro, and 5) a significant increase in
IL-7-driven proliferative expansion of pro-B and pre-B cells in
vitro. Because Btk has been reported to be in the pre-BCR signal-
ing pathway in the mouse (5, 22), our findings implicate pre-BCR
signaling in the control of CD2, CD25, CD43, BP-1, and SLC
expression, IL-7 responsiveness, and the transit time through the
small pre-B cell stage.
As pre-B cell production in Btk mice is normal, we conclude
that the inefficient down-regulation of BP-1, CD43, and SLC ex-
pression and up-regulation of CD2 and CD25 do not affect the
proliferative capacities of pre-B cells in vivo. Nevertheless, Btk
large pre-B cells manifested increased proliferative expansion in
vitro, when compared with Btk cells. The finding of significantly
increased surface SLC expression on these Btk large pre-B cells
(when compared with Btk cells) would support the hypothesis by
Melchers et al. (14) that large c pre-B cells stop cycling when
they run out of a sufficient number of assembled pre-BCR mole-
cules per cell. This is not necessarily in conflict with our finding
that the increased cytoplasmic SLC expression in Btk pre-B cells
did not result in increased proliferation in vivo. It is very possible
that only the level of membrane SLC expression may correlate
with the proliferative capacity of pre-B cells, and we were unable
to detect differences between Btk and Btk large pre-B cells in
vivo in membrane SLC expression levels.
Btk and L chain rearrangement
We have previously found that Btk mice show reduced  L chain
usage, which could either result from a defect in receptor editing
or alternatively from a decreased rate or efficiency of  L chain
rearrangement (20). Although by crossing 3-83  autoantibody
transgenic mice into Btk mice we have shown that Btk is not
essential for receptor editing (20), a possibility remained that the
extent of L chain replacement events is reduced in Btk mice.
However, our BrdU-labeling experiments, in which we identified a
3-h delay at the small pre-B cell stage in Btk mice, clearly argue
against this possibility. Reduction of the level of receptor editing
in Btk mice would have the opposite effect of a more rapid transit
through the small pre-B cell compartment, as B cells targeted for
receptor editing were recently shown to be specifically delayed in
this compartment for at least 2 h (33). Therefore, the finding of a
3-h delay supports a role for Btk in the regulation of the initiation
of L chain rearrangement events. As both  and  Btk cells
are equally delayed, this cannot explain the observed reduced 
usage in Btk mice (20). However, we conclude that the absence
of Btk specifically affects the production rate of  immature B
cells, as our linear regression analysis (Fig. 2C) revealed a lower
slope value for  cells in Btk mice (1.3) than in Btk mice
(1.7), while the values for  cells were similar (1.2 and 1.3).
FIGURE 5. Phenotypic characterization of IL-7-driven BM cultures
from Btk and Btk mice. The expression profiles of the indicated surface
and intracellular markers are displayed as histogram overlays of Btk (thin
lines) and Btk mice (bold lines). The histogram plots of the first column
(the large sIgM cells) include the background stainings of B220 (S17
stromal) cells, as negative controls (dotted lines). This is not shown for
CD43, as the B220 fraction in the cultures expressed CD43. Large and
small IgM cells were gated on the basis of FSC characteristics. Results
shown are representative of 2–6 mice per group.
FIGURE 6. Btk affects IL-7 responsiveness in pro-B cells. A, Prolifer-
ative responses of Btk and Btk RAG-1/ B cell precursors to IL-7, as
determined by [3H]thymidine incorporation after 7 days of culture. B, BP-1
expression profiles are displayed as histograms for B220 cells, either
uncultured or after 5 days of culture in the presence of IL-7, from Btk
(thin lines) and Btk (bold lines) RAG-1/ BM. Data are representative
of four experiments using two mice per group.
2701The Journal of Immunology
In this context, it is unknown whether Btk signaling directly or
indirectly regulates the activation of the L chain loci, or alterna-
tively, whether Btk acts by mediating developmental progression
to a pre-B cell stage in which L chain rearrangements are initiated.
The latter possibility would be consistent with the delayed mod-
ulation of the expression of SLC, BP-1, CD43, CD2, and CD25.
The finding that the expression of germline  transcripts is first
detected in vivo in large cycling CD25 pre-B cells would be
consistent with a role for pre-BCR signaling the opening of the L
chain loci for rearrangement (29, 43). However, additional exper-
iments would be needed to address this issue, as it has been shown
that productive L chain rearrangement can also be induced by IL-7
withdrawal of pre-BCR-deficient 5/ or JH/ pre-B cells in
vitro (14, 44).
The size of the immature B cell pool and the turnover of im-
mature B cells were reported to be essentially normal in xid or
Btk mice (16–18, 45). Nevertheless, we previously observed a
selective disadvantage of Btk cells at the transition from pre-B
cells to immature B cells in the BM, which we determined in an in
vivo competition analysis in Btk/ heterozygous female mice
(17). In the immature B cell subset, we found lacZ expression
values of 30%, whereas in the absence of a competitive disad-
vantage, Btk/lacZ cells would be expected to represent 50%
of any B cell subpopulation. The finding of a 3-h delay in produc-
tion of immature B cells in Btk mice would explain the observed
selective disadvantage of Btk-deficient cells in Btk/
female mice.
Btk and IL-7 responsiveness
An inhibitory effect of Btk on proliferation of B-lineage cells in
long-term Whitlock-Witte BM cultures has previously been re-
ported (46). However, analysis of growth kinetics of cultures es-
tablished from mixtures of WT and xid cells indicated that the
observed differences resulted from changes in the BM microenvi-
ronment associated with the xid mutation. In contrast, our separate
analyses of lacZ and lacZ cells in the BM cultures from Btk/
mice showed that increased IL-7 responsiveness is an intrinsic fea-
ture of Btk pre-B cells. This would be consistent with the finding
of an increased frequency of CFU responsive to IL-7 by limit-
ing dilution analysis of day 15 fetal liver cells from CBA/N xid
mice (47).
Finally, crosses of Btk-deficient and RAG-1-deficient mice
showed that IL-7-dependent expansion in vitro is constrained by
an inhibitory signal mediated by Btk, even before the expression of
 H chain. Cross-linking of the Ig signaling component of the
(pre-)BCR, which is expressed on the cell surface in c pro-B
cells in association with calnexin induced a rapid phosphorylation
of several intracellular signaling molecules, including Btk (22, 48).
Therefore, it is possible that Btk-mediated Ig/calnexin signaling
would serve to stop pro-B cell proliferation to facilitate V(D)J
recombination, which is exclusively initiated in the G0/G1 cell cy-
cle phase (49). This hypothesis may be supported by a significant
reduction of the level of VH to DJH rearrangements observed in
Ig-deficient mice (50), which would then be explained by a re-
duced signal to make pro-B cells competent to undergo VH-DJH
rearrangement (48). In this context, it has been shown previously
that in later stages of B cell development, modulation of the IL-7
responsiveness is dependent on pre-BCR and BCR signaling (51,
52). However, it is very possible that in pro-B cells, Btk may
function in a pathway that is unrelated to the Ig/calnexin com-
plex, as Btk has been implicated in signaling of various other re-
ceptors, including IL-5R, CD38, IL-10R, and FcRI (1, 2).
Taken together, our findings implicate Btk in two different path-
ways in early B cell development. First, Btk is required for the
efficient developmental progression of cytoplasmic  pre-B cells,
as Btk was shown to be involved in BP-1, CD43, and SLC down-
regulation, CD2 and CD25 up-regulation, and the rate of transit
through the small pre-B cell compartment. Additional experiments
are required to show whether Btk-mediated pre-BCR signaling di-
rectly or indirectly influences the expression of SLC, germline ,
or  transcripts or the RAG genes. Second, the IL-7-driven BM
culture experiments indicate a role for Btk as a pro- and pre-BCR
associated negative regulator of IL-7 expansion. Although XLA
patients may occasionally have a significantly increased pro-B cell
compartment (12, 53), in general there is no absolute pro-B ex-
pansion in XLA. Obviously, both in the mouse and in humans,
other signaling molecules or pathways must be able to compensate
for the loss of Btk in pro-B cells in vivo.
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